000 | 01292 a2200385 4500 | ||
---|---|---|---|
005 | 20250512203209.0 | ||
264 | 0 | _c19840719 | |
008 | 198407s 0 0 eng d | ||
022 | _a0308-2261 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcClelland, D B | |
245 | 0 | 0 |
_aClinical use of immunoglobulins. _h[electronic resource] |
260 |
_bClinics in haematology _cFeb 1984 |
||
300 |
_a39-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aAutoimmune Diseases _xtherapy |
650 | 0 | 4 |
_aBlood Transfusion _xmethods |
650 | 0 | 4 |
_aChickenpox _xprevention & control |
650 | 0 | 4 |
_aEndotoxins _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatitis, Viral, Human _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunization, Passive _xadverse effects |
650 | 0 | 4 |
_aImmunoglobulin G _xclassification |
650 | 0 | 4 |
_aImmunoglobulins _xdeficiency |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPseudomonas Infections _xprevention & control |
650 | 0 | 4 |
_aReceptors, Fc _xphysiology |
650 | 0 | 4 | _aReceptors, IgG |
650 | 0 | 4 |
_aRubella _xprevention & control |
650 | 0 | 4 |
_aTetanus _xprevention & control |
700 | 1 | _aYap, P L | |
773 | 0 |
_tClinics in haematology _gvol. 13 _gno. 1 _gp. 39-74 |
|
999 |
_c6233035 _d6233035 |